Literature DB >> 22787043

Contribution of decreased serotonin release to the antidyskinetic effects of deep brain stimulation in a rodent model of tardive dyskinesia: comparison of the subthalamic and entopeduncular nuclei.

Meaghan C Creed1, Clement Hamani, Alanna Bridgman, Paul J Fletcher, José N Nobrega.   

Abstract

Mechanisms whereby deep brain stimulation (DBS) of the subthalamic nucleus (STN) or internal globus pallidus (GPi) reduces dyskinesias remain largely unknown. Using vacuous chewing movements (VCMs) induced by chronic haloperidol as a model of tardive dyskinesia (TD) in rats, we confirmed the antidyskinetic effects of DBS applied to the STN or entopeduncular nucleus (EPN, the rodent homolog of the GPi). We conducted a series of experiments to investigate the role of serotonin (5-HT) in these effects. We found that neurotoxic lesions of the dorsal raphe nuclei (DRN) significantly decreased HAL-induced VCMs. Acute 8-OH-DPAT administration, under conditions known to suppress raphe neuronal firing, also reduced VCMs. Immediate early gene mapping using zif268 in situ hybridization revealed that STN-DBS inhibited activity of DRN and MRN neurons. Microdialysis experiments indicated that STN-DBS decreased 5-HT release in the dorsolateral caudate-putamen, an area implicated in the etiology of HAL-induced VCMs. DBS applied to the EPN also suppressed VCMs but did not alter 5-HT release or raphe neuron activation. While these findings suggested a role for decreased 5-HT release in the mechanisms of STN DBS, further microdialysis experiments showed that when the 5-HT lowering effects of STN DBS were prevented by pretreatment with fluoxetine or fenfluramine, the ability of DBS to suppress VCMs remained unaltered. These results suggest that EPN- and STN-DBS have different effects on the 5-HT system. While decreasing 5-HT function is sufficient to suppress HAL-induced VCMs, 5-HT decrease is not necessary for the beneficial motor effects of DBS in this model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22787043      PMCID: PMC6622267          DOI: 10.1523/JNEUROSCI.1196-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  44 in total

1.  Introduction: What makes an antipsychotic atypical?

Authors:  S M Stahl
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

2.  Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats.

Authors:  Peter Turrone; Gary Remington; Shitij Kapur; José N Nobrega
Journal:  Neuropsychopharmacology       Date:  2003-07-02       Impact factor: 7.853

Review 3.  Pathophysiology of antipsychotic drug-induced movement disorders.

Authors:  Daniel E Casey
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

Review 4.  Effects of antipsychotic drugs on serotonin receptors.

Authors:  H Y Meltzer; J F Nash
Journal:  Pharmacol Rev       Date:  1991-12       Impact factor: 25.468

Review 5.  Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

Authors:  K D Alex; E A Pehek
Journal:  Pharmacol Ther       Date:  2006-10-17       Impact factor: 12.310

Review 6.  The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?

Authors:  Peter Turrone; Gary Remington; José N Nobrega
Journal:  Neurosci Biobehav Rev       Date:  2002-05       Impact factor: 8.989

7.  Metabolic changes following subthalamotomy for advanced Parkinson's disease.

Authors:  P C Su; Y Ma; M Fukuda; M J Mentis; H M Tseng; R F Yen; H M Liu; J R Moeller; D Eidelberg
Journal:  Ann Neurol       Date:  2001-10       Impact factor: 10.422

Review 8.  Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies?

Authors:  Giuseppe Di Giovanni; Vincenzo Di Matteo; Massimo Pierucci; Arcangelo Benigno; Ennio Esposito
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

9.  Dopamine efflux in the rat striatum evoked by electrical stimulation of the subthalamic nucleus: potential mechanism of action in Parkinson's disease.

Authors:  Kendall H Lee; Charles D Blaha; Brent T Harris; Shannon Cooper; Frederick L Hitti; James C Leiter; David W Roberts; Uhnoh Kim
Journal:  Eur J Neurosci       Date:  2006-02       Impact factor: 3.386

10.  Induction of immediate early gene expression by high-frequency stimulation of the subthalamic nucleus in rats.

Authors:  T Schulte; S Brecht; T Herdegen; M Illert; H M Mehdorn; W Hamel
Journal:  Neuroscience       Date:  2006-02-07       Impact factor: 3.590

View more
  10 in total

Review 1.  In vitro and in vivo neuronal electrotaxis: a potential mechanism for restoration?

Authors:  Ali Jahanshahi; Lisa-Maria Schönfeld; Evi Lemmens; Sven Hendrix; Yasin Temel
Journal:  Mol Neurobiol       Date:  2013-11-16       Impact factor: 5.590

2.  Modification of spectral features by nonhuman primates.

Authors:  Daniel J Weiss; Cara F Hotchkin; Susan E Parks
Journal:  Behav Brain Sci       Date:  2014-12       Impact factor: 12.579

Review 3.  Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.

Authors:  P De Deurwaerdère; M Lagière; M Bosc; S Navailles
Journal:  Exp Brain Res       Date:  2013-04-25       Impact factor: 1.972

Review 4.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

Review 5.  Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.

Authors:  Maryka Quik; Danhui Zhang; Xiomara A Perez; Tanuja Bordia
Journal:  Pharmacol Ther       Date:  2014-05-14       Impact factor: 12.310

6.  Time and frequency-dependent modulation of local field potential synchronization by deep brain stimulation.

Authors:  Clinton B McCracken; Zelma H T Kiss
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

Review 7.  Potential Application of Electrical Stimulation in Stem Cell-Based Treatment against Hearing Loss.

Authors:  Mingliang Tang; Xiaoqian Yan; Qilin Tang; Rongrong Guo; Peng Da; Dan Li
Journal:  Neural Plast       Date:  2018-05-08       Impact factor: 3.599

8.  Deep Brain Stimulation Modified Autism-Like Deficits via the Serotonin System in a Valproic Acid-Induced Rat Model.

Authors:  Han-Fang Wu; Yi-Ju Chen; Ming-Chia Chu; Ya-Ting Hsu; Ting-Yi Lu; I-Tuan Chen; Po See Chen; Hui-Ching Lin
Journal:  Int J Mol Sci       Date:  2018-09-19       Impact factor: 5.923

9.  Cellular, molecular, and clinical mechanisms of action of deep brain stimulation-a systematic review on established indications and outlook on future developments.

Authors:  Martin Jakobs; Anton Fomenko; Andres M Lozano; Karl L Kiening
Journal:  EMBO Mol Med       Date:  2019-04       Impact factor: 12.137

10.  Pulsed Electrical Stimulation Enhances Consistency of Directional Migration of Adipose-Derived Stem Cells.

Authors:  Mi Hee Lee; Ye Jin Park; Seung Hee Hong; Min-Ah Koo; Minyoung Cho; Jong-Chul Park
Journal:  Cells       Date:  2021-10-22       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.